Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICP-488 in Moderate to Severe Plaque Psoriasis
NCT06842199Phase 3Recruiting
- Sponsor
- InnoCare Pharma
- Start
- Mar 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icp-488 in plaque psoriasis, sponsored by InnoCare Pharma. Started Mar 2025; status: recruiting.
02
Drugs
icp-488
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06842199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06842199.